Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iodine tincture is a traditional antiseptic solution typically composed of elemental iodine and an iodide salt (such as sodium iodide or potassium iodide) dissolved in a mixture of ethanol and water. It is primarily utilized for skin disinfection prior to medical procedures, including blood culture collection and catheter insertion, to mitigate the risk of healthcare-associated infections like bacteremia. Its mechanism of action is broad-spectrum and non-specific; free iodine rapidly penetrates the cell walls of microorganisms and acts as a potent oxidizing agent, disrupting essential proteins, nucleotides, and fatty acids, which leads to rapid cell death. Clinical studies, including those conducted by the University of Michigan, have compared its efficacy against other antiseptics like povidone-iodine and chlorhexidine gluconate, often finding it highly effective for reducing contamination rates in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iodine tincture (University of Michigan).